Overview

Observational Study of Safety and Efficacy of LevemirĀ® in Type 2 Diabetes

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The study is conducted in Asia. The aim of this observational study is to evaluate the weight change from baseline while using LevemirĀ® in subjects with type 2 diabetes mellitus under normal clinical practice conditions in India.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir
Insulin, Globin Zinc